drugset / Trial / NCT05365425
Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Phase 4
Recruiting
56 enrolled
Seoul National University Bundang Hospital
Daewon Pharmaceutical Co., Ltd. · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a randomized controlled study to assess the effect of choline fenofibrate compared with policosanol in Korean T2DM patients with asymptomatic atherosclerosis.
Timeline
- Start
- 2023-06-01
- Primary completion
- 2026-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABT-335 | Small molecule | 178.8 mg | Oral |
| Comparator | Policosanol | Small molecule | 10 mg | Oral |